The U.S. House was frozen stuck this morning after the new Republican majority splintered yesterday, the first day of the 118th Congress, over who should be the next House speaker.
Representatives cannot be sworn in and the House cannot begin
…
Category: Legislative
President Biden on Dec. 29 signed a $1.7 trillion omnibus appropriations bill for fiscal year 2023 that gave the 340B drug pricing program a slight funding boost.
The U.S. Health Resources and Services Administration’s Office of Pharmacy Affairs will get
…
U.S. House and Senate appropriations committees want federal healthcare officials to brief them by April “on actions taken to safeguard covered entities’ lawful access to discounted drugs” under the 340B program.
The directive to the Health Resources and Services Administration
…
The 117th Congress appears destined to end without further action on the 340B program.
The House and Senate are on track to finish all work for the year by no later than Friday, Dec. 23. According to news reports yesterday,
…
The Michigan Senate has defeated legislation that hospitals say would have removed language from a nearly year-old state law that stops payers, pharmacy benefit managers, or other third parties from requiring 340B claims modifiers except as required to prevent Medicaid
…
Henry Waxman, a California Democrat who was one of the original sponsors of the 340B law when it was created in 1992, says in a commentary in Health Affairs that criticism of the drug discount program often “reflect[s] a misunderstanding
…
Be prepared for a lot more attention on the 340B program in the upcoming Congress, 340B Report Publisher and CEO Ted Slafsky says in his latest column for medication management solutions company Omnicell.
340B was a hot topic in Congress
…
The Democratic vice chair of the U.S. House Energy & Commerce Committee said during a media event yesterday she hopes Congress will address healthcare providers’ concerns about the 340B program during its lame duck session scheduled to end Dec. 15.
…
U.S. Sen. Mike Braun (R-Ind.), whom 340B covered entities have considered both a friend and foe, has decided to run for governor of Indiana in 2024 rather than seek reelection to the Senate.
A senator since 2019, Braun serves on
…
Separating the 340B drug discount program into one for hospitals and another for non-hospital healthcare providers would be the wrong response to drug company denials of 340B pricing when providers use contract pharmacies, AIDS Healthcare Foundation said yesterday.
“A new
…